Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New developments in the treatment of acute myeloid leukemia.

Oncology (Williston Park, N.Y.) - 1 Nov 2000

Radich J, Sievers E

Abstract excerpt

Curative therapy for acute myeloid leukemia (AML) remains unsatisfactory. However, three recent advances may play an important role in determining how AML is treated in the near future. First, the development of targeted antibody therapy using the anti-CD33-calicheamicin conjugate (gemtuzumab ozogamicin, Mylotarg) represents a novel targeted approach to the killing of leukemia cells. Second, modern molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoglycosides
Share to Antibodies, Monoclonal, Humanized
Share to Antigens, Differentiation, Myelomonocytic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Combined Modality Therapy

Share to Immunotoxins

Share to Neoplasm, Residual

Share to Sialic Acid Binding Ig-like Lectin 3

Source

Identifiers

PMID: 11195406

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New developments in the treatment of acute myeloid leukemia.PMID 11195406Read ↗

New agents for the treatment of acute myeloid leukemia.Semantic proximity Read ↗

Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy.Semantic proximity Read ↗

Molecularly targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents.Semantic proximity Read ↗

Gemtuzumab ozogamicin in acute myeloid leukemia.Semantic proximity Read ↗

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia TreatmentSemantic proximity Read ↗

Molecular targeting in acute myeloid leukemiaSemantic proximity Read ↗

Targeting treatment in AML.Semantic proximity Read ↗

New prognostic markers in acute myeloid leukemia: perspective from the clinic.Semantic proximity Read ↗

Molecularly targeted therapy in acute myeloid leukemia.Semantic proximity Read ↗

Minimal residual disease in acute myeloid leukemia: coming of age.Semantic proximity Read ↗

Development of Minimal Residual Disease–Directed Therapy in Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.